Ischemic preconditioning requires opening of pannexin-1/P2X7 channels not only during preconditioning but again after index ischemia at full reperfusion

Molecular and Cellular Biochemistry

Volumn 351, Issue 1-2, 2011, Pages 77-84

  Vessey, Donald A ^a,b   Li, Luyi ^a   Kelley, Michael ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; G protein coupled receptors; Ischemia reperfusion injury; Ischemic preconditioning; P2X7 receptor; Pannexin 1 hemichannels

Indexed keywords

ADENOSINE; BRILLIANT BLUE; CARBENOXOLONE; CELL PROTEIN; ION CHANNEL; MEFLOQUINE; PANNEXIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PURINERGIC P2X7 RECEPTOR; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG PROTEIN BINDING; EX VIVO STUDY; HEART; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INHIBITION KINETICS; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CONNEXINS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X7; REPERFUSION INJURY;

RATTUS;

EID: 79953721923     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0713-9     Document Type: Article

References (28)

1. Jennings RB, Reimer KA (1991) The cell biology of acute myocardial ischemia. Ann Rev Med 42:225-246
2. Vessey DA, Li L, Honbo N, Karliner JS (2009) Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. Am J Physiol Heart Circ Physiol 297:H1429-H1435
3. Buja LM, Entman ML (1998) Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98:1355-1357
4. Hansen PR (1995) Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur Heart J 16:734-740
5. Maxwell SR, Lip GY (1997) Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58:95-117 (Pubitemid 27064668)
6. Vessey DA, Li L, Kelley M, Karliner JS (2008) Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. Biochem Biophys Res Commun 375:425-429
7. Zhao ZQ, Vinten-Johansen J (2002) Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55:438-455
8. Gill C, Mestril R, Samali A (2002) Losing heart: the role of apoptosis in heart disease-a novel therapeutic target? FASEB J 16:135-146
9. Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66:913-931 (Pubitemid 20126423)
10. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Hermann HC, Laskey WK (1990) Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical hemodynamic, and metabolic features. Circulation 82:2044-2051
11. Gross ER, Gross GJ (2006) Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70:212-221
12. Hausenloy DJ, Tsang A, Yellon DM (2004) The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15:69-75 (Pubitemid 40693390)
13. Murphy E, Steenbergen C (2008) Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88:581-609 (Pubitemid 351520088)
14. Vessey DA, Li L, Kelley M (2010) Pannexin-1/P2X7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning. J Cardiovasc Pharmacol Ther 15:190-195
15. Vessey D, Kelley M, Li L, Huang Y, Zhou H-Z, Zhu BQ, Karliner JS (2006) Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 12:BR318-BR324
16. Vessey DA, Kelley M, Zhang J, Li L, Tao R, Karliner JS (2007) Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart. J Biochem Mol Toxicol 21:273-279 (Pubitemid 350006284)
17. Vessey DA, Kelley M, Li L, Huang Y (2009) Sphingosine protects aging hearts from ischemia/reperfusion injury. Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning. Oxid Med Cell Longev 2:146-151
18. Locovei S, Scemes E, Qiu F, Spray DC, Dahl G (2007) Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Lett 581:483-488 (Pubitemid 46149626)
19. Qui F, Dahl G (2008) A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am J Physiol 296: C250-C255
20. Oudit GY, Penninger JM (2009) Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 82:250-260
21. Vessey DA, Li L, Kelley M, Karliner JS (2008) Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. J Biochem Mol Toxicol 22: 113-118 (Pubitemid 351657194)
22. Cohen MV, Downey JM (2007) Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 103:203-215
23. Song G, Ouyang G, Bao S (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9:59-71
24. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288:H971-H976 (Pubitemid 40139686)
25. Solenkova NV, Solodushko V, Cohen MV, Downey JM (2006) Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol 290:H441-H449
26. Harrison GJ, Willis RJ, Headrick JP (1998) Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res 40:74-87 (Pubitemid 28435431)
27. Zhao Z-Q, Vinten-Johansen J (2006) Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 70:200-211
28. 2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 43:262-271